Cell cycle arrest and p53 prevent ON-target megabase-scale rearrangements induced by CRISPR-Cas9

G. Cullot, J. Boutin, S. Fayet, F. Prat, J. Rosier, D. Cappellen, I. Lamrissi, P. Pennamen, J. Bouron, S. Amintas, C. Thibault, I. Moranvillier, E. Laharanne, J. P. Merlio, V. Guyonnet-Duperat, J. M. Blouin, E. Richard, S. Dabernat, F. Moreau-Gaudry () and A. Bedel ()
Additional contact information
G. Cullot: Bordeaux University, INSERM, BRIC, U1312
J. Boutin: Bordeaux University, INSERM, BRIC, U1312
S. Fayet: Bordeaux University, INSERM, BRIC, U1312
F. Prat: Bordeaux University, INSERM, BRIC, U1312
J. Rosier: Bordeaux University, INSERM, BRIC, U1312
D. Cappellen: Bordeaux University, INSERM, BRIC, U1312
I. Lamrissi: Bordeaux University, INSERM, BRIC, U1312
P. Pennamen: CHU de Bordeaux, department of medical genetics
J. Bouron: CHU de Bordeaux, department of medical genetics
S. Amintas: Bordeaux University, INSERM, BRIC, U1312
C. Thibault: Bordeaux University, INSERM, BRIC, U1312
I. Moranvillier: Bordeaux University, INSERM, BRIC, U1312
E. Laharanne: CHU de Bordeaux, Tumor Biology and Tumor Bank Laboratory
J. P. Merlio: Bordeaux University, INSERM, BRIC, U1312
V. Guyonnet-Duperat: Bordeaux University, INSERM, BRIC, U1312
J. M. Blouin: Bordeaux University, INSERM, BRIC, U1312
E. Richard: Bordeaux University, INSERM, BRIC, U1312
S. Dabernat: Bordeaux University, INSERM, BRIC, U1312
F. Moreau-Gaudry: Bordeaux University, INSERM, BRIC, U1312
A. Bedel: Bordeaux University, INSERM, BRIC, U1312

Nature Communications, 2023, vol. 14, issue 1, 1-16

Abstract: Abstract The CRISPR-Cas9 system has revolutionized our ability to precisely modify the genome and has led to gene editing in clinical applications. Comprehensive analysis of gene editing products at the targeted cut-site has revealed a complex spectrum of outcomes. ON-target genotoxicity is underestimated with standard PCR-based methods and necessitates appropriate and more sensitive detection methods. Here, we present two complementary Fluorescence-Assisted Megabase-scale Rearrangements Detection (FAMReD) systems that enable the detection, quantification, and cell sorting of edited cells with megabase-scale loss of heterozygosity (LOH). These tools reveal rare complex chromosomal rearrangements caused by Cas9-nuclease and show that LOH frequency depends on cell division rate during editing and p53 status. Cell cycle arrest during editing suppresses the occurrence of LOH without compromising editing. These data are confirmed in human stem/progenitor cells, suggesting that clinical trials should consider p53 status and cell proliferation rate during editing to limit this risk by designing safer protocols.

Date: 2023
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41467-023-39632-w Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-39632-w

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-023-39632-w

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().